The EMEA 3D CBCT systems market is expected to reach USD 300.4 million by 2023 from USD 194.3 million in 2018, at a CAGR of 9.0%. The key factors driving the growth of this market include the growing prevalence of dental disorders, growing demand for cosmetic dentistry and other dental procedures, increasing healthcare expenditure, and the frequent launch of new products in this market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=148086734
In this report, the EMEA 3D CBCT systems market is segmented based on application, end user, and region. On the basis of application, the market is broadly segmented into dental and non-dental applications. The dental applications segment is further subsegmented into implantology, oral and maxillofacial surgery, orthodontics, endodontics, and other dental applications. The non-dental applications segment is subsegmented into ENT and radiology. Dental application segment is expected to register the highest growth during the forecast period. Large share of this segment can be attributed to the rapidly growing geriatric population, increase in the prevalence of dental diseases/conditions, low radiation exposure from CBCT compared to conventional analog X-rays, increasing demand for cosmetic dentistry, and growing medical tourism for dental services.
The orthodontics segment is expected to register the highest CAGR during the forecast period. The wide applications of CBCT in orthodontics will provide significant growth opportunities for CBCT system manufacturers in the orthodontics sector in the next few years
On the basis of end user, the EMEA 3D CBCT systems market is segmented into hospitals & clinics and diagnostic centers. Hospitals and clinics end-user segment is expected to register the highest growth during the forecast period. The large share of this segment is attributed to the increasing number of hospitals and private clinics worldwide, increasing number of people opting for various dental procedures, and the rapid adoption of advanced technologies by both small and large hospitals as well as some private clinics in this region.
Geographically, the EMEA 3D CBCT systems market is segmented into Europe, Middle East, and Africa. Europe is expected to witness the highest CAGR during the forecast period. A favorable reimbursement scenario and presence of a large number of prominent players (leading to a greater availability and accessibility of CBCT systems for end users in this region) are considered as positive indicators for high market growth.
